Vertex Pharmaceuticals Incorporated (OQ:VRTX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for VRTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 26th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 20/19 Jun 19/19 Arbuckle Stuart A Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,125  
Jun 20/19 Jun 19/19 Arbuckle Stuart A Direct Ownership Common Stock S - Open market or private sale -2,125 $181.89
Jun 20/19 Jun 19/19 Arbuckle Stuart A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,125 $131.89
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -56,030  
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Common Stock S - Open market or private sale -4,249 $176.11
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Common Stock S - Open market or private sale -51,781 $175.33
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 56,030 $77.31
Jun 4/19 Jun 3/19 Bhatia Sangeeta N. Direct Ownership Common Stock S - Open market or private sale -320 $167.78
Jun 4/19 Jun 3/19 Bhatia Sangeeta N. Direct Ownership Common Stock S - Open market or private sale -400 $166.52
Jun 4/19 Jun 1/19 Young William D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,381  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for VRTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 26th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 20/19 Jun 19/19 Arbuckle Stuart A Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,125  
Jun 20/19 Jun 19/19 Arbuckle Stuart A Direct Ownership Common Stock S - Open market or private sale -2,125 $181.89
Jun 20/19 Jun 19/19 Arbuckle Stuart A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,125 $131.89
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -56,030  
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Common Stock S - Open market or private sale -4,249 $176.11
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Common Stock S - Open market or private sale -51,781 $175.33
Jun 20/19 Jun 18/19 Leiden Jeffrey M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 56,030 $77.31
Jun 4/19 Jun 1/19 Young William D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,381  
Jun 4/19 Jun 1/19 Ullian Elaine Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 6,659  
Jun 4/19 Jun 1/19 Sachs Bruce I Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 1,801  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $VRTX

StockTwits